Donor and recipient leukocytes in organ allografts of recipients with variable donor-specific tolerance: With particular reference to chronic rejection

Liver Transplantation

Volumn 6, Issue 6, 2000, Pages 686-702

  Ichikawa, Naoya ^a   Demetris, Anthony J ^a   Starzl, Thomas E ^a   Ye, Qing ^a   Okuda, Toyokazu ^a   Chun, Hyo Jin ^a   Liu, Kaihong ^a   Kim, Young Myeong ^a   Murase, Noriko ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD11 ANTIGEN; TACROLIMUS;

ALLOGRAFT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CLONAL ANERGY; CONTROLLED STUDY; DENDRITIC CELL; FLOW CYTOMETRY; GRAFT REJECTION; HEART TRANSPLANTATION; HISTOPATHOLOGY; IMMUNOCYTOCHEMISTRY; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; LEUKOCYTE MIGRATION; LIVER TRANSPLANTATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0033733644     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1053/jlts.2000.19029     Document Type: Article

References (88)

1. Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semi-allogeneic system
2. A biological role for the major histocompatibility antigens
3. The discovery of MHC restriction
4. Antigen localization and migration in immunity and tolerance
5. Cell migration, chimerism, and graft acceptance
6. Systemic chimerism in human female recipients of male livers
7. Cell migration and chimerism after whole-organ transplantation: The basis of graft acceptance
8. Graft-versus-host disease (GVHD) after BN to LEW compared to LEW to BN rat intestinal transplantation under FK 506
9. Hematolymphoid cell trafficking, microchimerism, and GVH reactions after liver, bone marrow, and heart transplantation
10. Murine liver allograft transplantation: Tolerance and donor cell chimerism
11. Variable chimerism, graft-versus-host disease, and tolerance after different kinds of cell and whole organ transplantation from Lewis to brown Norway rats
12. Lymphoid/non-lymphoid compartmentalization of donor leukocyte chimerism in rat recipients of heart allografts, with or without adjunct bone marrow
13. Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution
14. The dendritic cell system and its role in immunogenicity
15. Microchimerism, dendritic cell progenitors and transplantation tolerance
16. Analysis of chronic rejection and obliterative arteriopathy. Possible contributions of donor antigen-presenting cells and lymphatic disruption
17. The major histocompatibility complex of the rat
18. A monoclonal antibody (L21-6) recognizing an invariant chain expressed on the cell surface in rats with the exception of the BN (RT1n): A study of tissue and strain distributions
19. The heterogeneity of mononuclear phagocytes in lymphoid organs: Distinct macrophage subpopulations in the rat recognized by monoclonal antibodies ED1, ED2, and ED3
20. Rat macrophage lysosomal membrane antigen recognized by monoclonal antibody ED1
21. Characterization and expression of the antigen present on resident rat macrophages recognized by monoclonal antibody ED2
22. Characterization of the tissue macrophage and the interstitial dendritic cell as distinct leukocytes normally resident in the connective tissue of rat heart
23. Early events in liver allograft rejection: Delineation of sites of simultaneous intragraft and recipient lymphoid tissue sensitization
24. Peritransplant tolerance induction in macaques: Early events reflecting the unique synergy between immunotoxin and deoxyspergualin
25. The lost chord: Microchimerism
26. Antigen persistence and time of T-cell tolerization determine the efficacy of tolerization protocols for prevention of skin graft rejection
27. Immunology taught by viruses
28. Antigen localization regulates immune responses in a dose- and time-dependent fashion: A geographical view of immune reactivity
29. Antiviral immunity
30. The RGD-containing domain of exogenous HIV-1 Tat inhibits the engulfment of apoptotic bodies by dendritic cells
31. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs
32. A discrete subpopulation of dendritic cells transports apoptotic intestinal epithelial cells to T cell areas of mesenteric lymph nodes
33. Consequences of cell death: Exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunohistostimulatory dendritic cells
34. The induction of tolerance by dendritic cells that have captured apoptotic cells
35. Redistribution of renal allograft-responding leukocytes during rejection. II. Kinetics and specificity
36. Migration of dendritic leukocytes from cardiac allografts into host spleens. A novel route for initiation of rejection
37. Costimulation pathways in host immune responses to allogeneic hepatocytes
38. A functional model of hepatocyte transplantation for in vivo immunologic studies
39. In vivo immunogenicity of purified allogeneic hepatocytes in a murine hepatocyte transplant model
40. Pathogenesis of a local graft versus host reaction: Immunogenicity of circulating host leukocytes
41. Transplant aspiration cytology in the evaluation of a renal allograft
42. Dendritic cell-lymphoid cell aggregation and major histocompatibility antigen expression during rat cardiac allograft rejection
43. Donor hematopoietic progenitor cells in nonmyeloablated rat recipients of allogeneic bone marrow and liver gtafts
44. Stable lung allograft outcome correlates with the presence of intragraft donor-derived leukocytes
45. Post-transplant obliterative bronchiolitis and other late lung sequelae in human heart-lung transplantation
46. Mixed chimerism as an approach for the induction of transplantation tolerance
47. The requirement for allogeneic chimerism for second transfer of tolerance from mixed allogeneic chimeras (A+B→A) to secondary recipients
48. Donor-recipient microchimerism and tolerance induction
49. Chimetism and transplantation tolerance: Cause and effect
50. Prolonged survival of actively enhanced rat renal allografts despite accelerated cellular infiltration and rapid induction of both class I and class II MHC antigens
51. Macrophage subpopulations in normal and transplanted heart and kidney tissues in the rat
52. Lymphocytic subsets and histopathologic changes associated with the development of heart transplant arteriosclerosis
53. Experimental graft arteriosclerosis. II. Immunocytochemical analysis of lesion development
54. Lymphocyte traffic and graft-versus-host disease after fully allogeneic small bowel transplantation
55. Donor dendritic cells after liver and heart allotransplantation under short-term immunosuppression
56. Split tolerance induced by orthotopic liver transplantation in mice
57. Ablation of 'tolerance' and induction of diabetes by viruses infection in viral antigen transgenic mice
58. Induction of diabetes is influenced by the infectious virus and local expression of MHC class I and tumor necrosis factor-α
59. The surface phenotype of dendritic cells purified from mouse thymus and spleen: Investigation of the CD8 expression by a subpopulation of dendritic cells
60. The linkage between T-cell and dendritic cell development in the mouse thymus
61. The evolution of self-tolerance: A new cell arises to meet the challenge of self-reactivity
62. Antibody-induced transplant arteriosclerosis is prevented by graft expression of anti-oxidant and anti-apoptotic genes
63. Mature lymphocyte apoptosis-immune regulation in a dynamic and unpredictable antigen environment
64. Extrathymic tolerance of mature T cells: Clonal elimination as a consequence of immunity
65. Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells
66. T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis
67. T cell priming versus T cell tolerance induced by synthetic peptides
68. Tolerance to rat liver allografts. III. Donor cell migration and tolerance-associated cytokine production in peripheral lymphoid tissues
69. Apoptosis within spontaneously accepted mouse liver allografts: Evidence for deletion of cytotoxic T cells and implications for tolerance induction
70. Apoptosis of T lymphocytes in liver and/or small bowel allografts during tolerance induction
71. Extrathymic T cell deletion and allogeneic stem cell engraftment induced with costimulatory blockade is followed by central T cell tolerance
72. Increased apoptosis of immunoreactive host cells and augmented donor leukocyte chimerism, not sustained inhibition of B7 molecule expression are associated with prolonged cardiac allograft survival: In mice preconditioned with immature donor dendritic cells plus anti-CD40L mAb
73. Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance
74. Requirement for T-cell apoptosis in the induction of peripheral transplantation tolerance
75. Chronic rejection
76. Commentary on Tilney NL: Chronic rejection
77. Nephron supply is a major determinant of long-term renal allograft outcome
78. Chronic rejection of rat renal allografts. II. The impact of prolonged ischemia time on transplant histology
79. Antigen-independent determinants of cadaveric kidney transplant failure
80. Cardiac transplantation in the rat. I. The effect of histocompatibility differences on graft arteriosclerosis
81. Cytokines, adhesion molecules, and the pathogenesis of chronic rejection of rat renal allografts
82. Chronic cardiac rejection in the LEW to F344 rat model: Blockade of CD28-B7 costimulation by CTLA4Ig modulates T cell and macrophage activation and attenuates arteriosclerosis
83. Blockade of T cell costimulation prevents development of experimental chronic allograft rejection
84. Synthetic MHC class I pepdde prolongs cardiac survival and attenuates transplant arteriosclerosis in the Lewis→Fischer 344 model of chronic allograft rejection
85. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways
86. Augmentation with bone marrow of donor leukocyte migration for kidney, liver, heart, and pancreas islet transplantation
87. Infusion of donor leukocytes to induce tolerance in organ allograft recipients
88. Assessment of the effects of cadaver donor bone marrow on kidney allograft recipient blood cell chimerism by a novel technique combining PCR and flow cytometry (PCR-FLOW)